Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Operating Leases (2023 - 2024)

Historic Operating Leases for Fennec Pharmaceuticals (FENC) over the last 2 years, with Q4 2024 value amounting to $2000.0.

  • Fennec Pharmaceuticals' Operating Leases changed 0.0% to $2000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $2000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $2000.0 for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q4 2024, Fennec Pharmaceuticals' Operating Leases is $2000.0, which was down 0.0% from $7000.0 recorded in Q3 2024.
  • Over the past 5 years, Fennec Pharmaceuticals' Operating Leases peaked at $17000.0 during Q1 2024, and registered a low of $2000.0 during Q4 2023.